Usted buscó: ipertrigliċeridimja (Maltés - Inglés)

ipertrigliċeridimja
hypertriglyceridaemia

ipertrigliċeridimja *
hypertriglyceridemia*

ipergliċemija, ipertrigliċeridimja
hyperglycaemia, hypertriglyceridaemia

anoressija iperkolesterolimja ipertrigliċeridimja
anorexia hypercholesterolemia hypertriglyceridaemia

dijabete mellitus, ipertrigliċeridimja
diabetes mellitus, hypertriglyceridemia*

ipertrigliċeridimja, ipokalċimija, iponatrimija
hypertriglyceridaemia, hypocalcaemia, hyponatraemia

tnaqqis fl- aptit, żieda fl- aptit ipertrigliċeridimja, anoressja
decreased appetite, increased appetite hypertriglyceridaemia, anorexia

metaboliżmu u fin - ipertrigliċeridimja nutrizzjoni mikożi opportunistika infezzjonijiet infestazzjonijiet disturbi vaskulari
endocrine disorders metabolism and nutrition disorders

- jekk għandek livelli għoljin ta ’ xaħam fid- demm (ipertrigliċeridimja)
you may need to stop taking these tablets 4 to 6 weeks before the operation, to reduce the risk of a blood clot.

ipertrigliċeridimja u l-aggravament tal-ipertrigliċeridimja, kultant sever, kienu osservati.
hypertriglyceridemia and aggravation of hypertriglyceridemia, sometimes severe, have been observed.

pankreatite kronika jew akuta bl-eċċezzjoni ta’ pankreatite akuta minħabba ipertrigliċeridimja severa
chronic or acute pancreatitis with the exception of acute pancreatitis due to severe hypertriglyceridaemia

dislipidimja (inkluż iperkolesterolimja u ipertrigliċeridimja) kienet irrappurtata f’pazjenti li jieħdu votubia.
dyslipidaemia (including hypercholesterolaemia and hypertriglyceridaemia) has been reported in patients taking votubia.

każijiet ta’ pankreatite ġew irrapurtati f’pazjenti li qed jieħdu kaletra, inklużi dawk li żvillupaw ipertrigliċeridimja.
cases of pancreatitis have been reported in patients receiving kaletra, including those who developed hypertriglyceridaemia.

terapija antiretrovirali kombinata ġiet assoċjata ma ’ anormalitajiet metaboliċi bħal ipertrigliċeridimja, iperkolesterolimja, reżistenza għall- insulina, ipergliċemija u iperlaktimja.
combination antiretroviral therapy has been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactaemia.

l- ipertrigliċeridimja u l- aggravament ta ’ l- ipertrigliċeridimja, kultant b' mod serju, kienu innutati.
hypertriglyceridemia and aggravation of hypertriglyceridemia, sometimes severe, have been observed.

disturbi fil- metaboliżmu u n- nutrizzjoni komuni: - tnaqqis fl- aptit, anoressija, ipertrigliċeridimja, dijabete mellitus.
metabolism and nutrition disorders common: - appetite decreased, anorexia, hypertriglyceridaemia, diabetes mellitus.

f’każijiet rari, bl-użu ta’ betaferon, kienet osservata pankreatite, li ta’ spiss kienet assoċjata ma’ ipertrigliċeridimja.
in rare cases, pancreatitis was observed with betaferon use, often associated with hypertriglyceridaemia.